Table 2.
Drug–drug interactions affected by R406 exposure
Co-administered drugs | Dosage of co-administered drugs (daily) | Dosage of fostamatinib (daily) | Analyte | Geometric mean ratio (90% CI) | References | |
---|---|---|---|---|---|---|
AUC | Cmax | |||||
Ketoconazole | 200 mg twice | 80 mg once | R406 | 2.02 (1.77–2.30) | 1.37 (1.23–1.53) | [54, 58] |
Verapamil | 80 mg three times | 150 mg once | R406 | 1.39 (1.08–1.80) | 1.06 (0.78–1.44) | [54, 58] |
Rifampicin | 600 mg once | 150 mg once | R406 | 0.25 (0.19–0.32) | 0.41 (0.30–0.56) | [54, 58] |
Rosuvastatin | 20 mg once | 100 mg twice | R406 | 1.10 (1.04–1.16) | 1.13 (1.02–1.25) | [54, 61, 66] |
Simvastatin | 40 mg once | 100 mg twice | R406 | 1.11 (1.01–1.22) | 1.12 (0.98–1.27) | [54, 61] |
Ranitidine | 150 mg once | 150 mg once | R406 | 0.97 (0.80–1.18) | 0.98 (0.71–1.34) | [49, 54] |
AUC area under the plasma concentration–time curve, CI confidence interval, Cmax maximum concentration, Ref. references